SUPN - Supernus Pharmaceuticals Inc. (SUPN) CEO Jack Khattar on Q3 2020 Results - Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (SUPN) Q3 2020 Earnings Conference Call November 04, 2020, 9:00 AM ET Company Participants Peter Vozzo - IR, Westwicke Jack Khattar - President and Chief Executive Officer Gregory Patrick - Retiring Chief Financial Officer James Kelly - New Chief Financial Officer Conference Call Participants Ken Cacciatore - Cowen and Company David Steinberg - Jefferies Annabel Samimy - Stifel David Amsellem - Piper Sandler Presentation Operator Good morning and welcome to the Supernus Pharmaceuticals Third Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative of Supernus Pharmaceuticals. You may begin. Peter Vozzo Thank you, Jimmy. Good morning, everyone and thank you for joining us today for Supernus Pharmaceuticals' third quarter 2020 financial results conference
For further details see:
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2020 Results - Earnings Call Transcript